Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy

Gynecologic Oncology

Volumn 104, Issue 1, 2007, Pages 139-144

  Bache, Matthias ^a   Holzapfel, Daniel ^a   Kappler, Matthias ^a   Holzhausen, Hans Jürgen ^a   Taubert, Helge ^a   Dunst, Jürgen ^a,b   Hänsgen, Gabriele ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cervical cancer; Hypoxia; Prognosis; Radiotherapy; Survivin

Indexed keywords

HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SURVIVIN;

ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXYGEN TISSUE LEVEL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; TISSUE OXYGENATION; TUMOR BIOPSY; UTERINE CERVIX CARCINOMA;

ADULT; AGED; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; FEMALE; HEMOGLOBINS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; OXYGEN; PARTIAL PRESSURE; PROGNOSIS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 33846020971     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.07.011     Document Type: Article

References (36)

1. Hockel M., Vorndran B., Schlenger K., Baussmann E., and Knapstein P.G. Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol. 51 2 (1993) 141-149
2. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol. 26 1 (1993) 45-50
3. Haensgen G., Krause U., Becker A., Stadler P., Lautenschlaeger C., Wohlrab W., et al. Tumor hypoxia, p53, and prognosis in cervical cancers. Int. J. Radiat. Oncol. Biol. Phys. 50 4 (2001) 865-872
4. Dunst J., Kuhnt T., Strauss G., Krause U., Pelz T., Koelbl H., et al. Anemia in cervical cancers: impact on survival, patterns of relapse and association with hypoxia and angiogenesis. Int. J. Radiat. Oncol. Biol. Phys. 56 3 (2003) 778-787
5. Vordermark D., and Brown J.M. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?. Strahlenther. Onkol. 179 12 (2003) 801-811
6. Altieri D.C. Validating Survivin as a cancer therapeutic target. Nat. Rev., Cancer 1 (2003) 46-54
7. Rodel F., Hoffmann J., Grabenbauer G.G., Papadopoulos T., Weiß C., Gunther K., et al. High Survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radio chemotherapy and surgical resection. Strahlenther. Onkol. 178 8 (2002) 426-435
8. Kappler M., Kohler T., Kampf C., Diestelkotter P., Wurl P., Schmitz M., et al. Increased Survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int. J. Cancer 95 6 (2001) 360-363
9. Wurl P., Kappler M., Meye A., Bartel F., Kohler T., Lautenschlager C., et al. Co-expression of Survivin and TERT and risk of tumor-related death in patients with soft-tissue sarcoma. Lancet 359 9310 (2002) 943-945
10. Yang L., Cao Z., Li F., Post D.E., Van Meir E.G., Zhong H., et al. Tumor-specific gene expression using the Survivin promoter is further increased by hypoxia. Gene Ther. 11 15 (2004) 1215-1223
11. O'Connor D.S., Schechner J.S., Adida C., Mesri M., Rothermel A.L., Li F., et al. Control of apoptosis during angiogenesis by Surviving expression in endothelial cells. Am. J. Pathol. 156 2 (2000) 393-398
12. Mesri M., Morales-Ruiz M., Ackermann E.J., Bennett C.F., Pober J.S., Sessa W.C., and Altieri D.C. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by Survivin targeting. Am. J. Pathol. 158 5 (2001) 1757-1765
13. Conway E.M., Zwerts F., Van Eygen V., DeVriese A., Nagai N., Luo W., et al. Survivin-dependent angiogenesis in ischemic brain: molecular mechanisms of hypoxia-induced up-regulation. Am. J. Pathol. 163 3 (2003) 935-946
14. Tran J., Master Z., Yu J.L., Rak J., Dumont D.J., and Kerbel R.S. A role for Survivin in chemoresistance of endothelial cells mediated by VEGF. Proc. Natl. Acad Sci. U. S. A. 99 7 (2002) 4349-4354
15. Zaffaroni N., Pennati M., and Daidone M.G. Survivin as a target for new anticancer interventions. J. Cell Mol. Med. 9 2 (2005) 360-372
16. Kappler M., Bache M., Bartel F., Kotzsch M., Panian M., Wurl P., et al. Knockdown of Survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. Cancer Gene Ther. 11 3 (2004) 186-193
17. Kappler M., Taubert H., Bartel F., Blumke K., Panian M., Schmidt H., et al. Radio sensitization, after a combined treatment of Survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line. Oncol. Rep. 13 1 (2005) 167-172
18. Zhu L., Fukuda S., Cordis G., Das D.K., and Maulik N. Anti-apoptotic protein Survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett. 508 3 (2001) 369-374
19. Frost M., Jarboe E.A., Orlicky D., Gianani R., Thompson L.C., Enomoto T., et al. Immunohistochemical localization of Survivin in benign cervical mucosa, cervical dysplasia and invasive squamous cell carcinoma. Am. J. Clin. Pathol. 175 5 (2002) 738-744
20. Singh A., Sharma H., Salhan S., Gupta S.D., Bhatla N., Jain S.K., et al. Evaluation of expression of apoptosis-related proteins and their correlation with HPV, telomerase activity, and apoptotic index in cervical cancer. Pathobiology 71 6 (2004) 314-322
21. Kim H.S., Shiraki K., and Park S.H. Expression of Survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Cancer Res. 22 2A (2002) 805-808
22. Lee J.P., Chang K.H., Han J.H., and Ryu H.S. Survivin, a novel anti-apoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. Int. J. Gynecol. Cancer 15 1 (2005) 113-119
23. Yoshida H., Sumi T., Hyun Y., Nakagawa E., Hattori K., Yasui T., et al. Expression of Survivin and matrix metalloproteinases in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Oncol. Rep. 10 1 (2003) 45-49
24. Harris A.L. Hypoxia-a key regulatory factor in tumor growth. Nat. Rev., Cancer 2 1 (2002) 38-47
25. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev., Cancer 3 10 (2003) 721-732
26. Lu Q.P., Cao T.J., Zhang Z.Y., and Liu W. Multiple gene differential expression patterns in human ischemic liver: safe limit of warm ischemic time. World J. Gastroenterol. 10 14 (2004) 2130-2133
27. Wei H.Y., Chen L.B., and Wang C.Y. Correlation of mRNA expression of hypoxia inducible factor-1alpha to biological features of pancreatic cancer. Ai Zheng 24 2 (2005) 184-188
28. Chang Q., Qin R., Huang T., Gao J., and Feng Y. Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer. Pancreas 32 3 (2006) 297-305
29. Kelleher D.K., Matthiensen U., Thews O., and Vaupel P. Tumor oxygenation in anemic rats: effects of erythropoietin treatment versus red blood cell transfusion. Acta Oncol. 34 3 (1995) 379-384
30. Kelleher D.K., Mattheinsen U., Thews O., and Vaupel P. Blood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic rats. Cancer Res. 56 20 (1996) 4728-4734
31. Saxena A., Yashar C., Taylor D.D., and Gercel-Taylor C. Cellular response to chemotherapy and radiation in cervical cancer. Am. J. Obstet. Gynecol. 192 5 (2005) 1399-1403
32. Hansgen G., Pigorsch S., Holzapfel D., Bache M., Holzhausen H.J., Taubert H., Molls M., et al. Pre-treatment Hif-1alpha-expression and its relationship to tumor oxygenation, hemoglobin level and its impact as a prognostic marker in patients with advanced cervical carcinoma treated by definitive radiotherapy. International Wolfsberg Meeting on Molecular Radiation Biology/Oncology (2004)
33. Vukovic V., Haugland H.K., Nicklee T., Morrison A.J., and Hedley D.W. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 61 20 (2001) 7394-7398
34. Haugland H.K., Vukovic V., Pintilie M., Fyles A.W., Milosevic M., Hill R.P., et al. Expression of hypoxia-inducible factor-1alpha in cervical carcinomas: correlation with tumor oxygenation. Int. J. Radiat. Oncol. Biol. Phys. 53 4 (2002) 854-861
35. Hutchison G.J., Valentine H.R., Loncaster J.A., Davidson S.E., Hunter R.D., Roberts S.A., et al. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix. Clin. Cancer Res. 10 24 (2004) 8405-8412
36. Mayer A., Wree A., Hockel M., Leo C., Pilch H., and Vaupel P. Lack of correlation between expression of HIF-1alpha protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res. 64 16 (2004) 5876-5881